PMC:7253235 / 1801-2003 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"73","span":{"begin":15,"end":33},"obj":"Disease"},{"id":"74","span":{"begin":35,"end":49},"obj":"Disease"},{"id":"75","span":{"begin":65,"end":80},"obj":"Disease"},{"id":"76","span":{"begin":104,"end":110},"obj":"Disease"},{"id":"77","span":{"begin":169,"end":178},"obj":"Disease"},{"id":"78","span":{"begin":185,"end":199},"obj":"Disease"}],"attributes":[{"id":"A73","pred":"tao:has_database_id","subj":"73","obj":"MESH:D011658"},{"id":"A74","pred":"tao:has_database_id","subj":"74","obj":"MESH:D006949"},{"id":"A75","pred":"tao:has_database_id","subj":"75","obj":"MESH:D050197"},{"id":"A76","pred":"tao:has_database_id","subj":"76","obj":"MESH:D009369"},{"id":"A77","pred":"tao:has_database_id","subj":"77","obj":"MESH:D007239"},{"id":"A78","pred":"tao:has_database_id","subj":"78","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"not limited to pulmonary fibrosis, hyperlipidemia, and worsening atherosclerosis. Those undergoing anti-cancer therapy are at theoretically increased susceptibility for infection, with type of cancer no"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T27","span":{"begin":15,"end":33},"obj":"Disease"},{"id":"T28","span":{"begin":35,"end":49},"obj":"Disease"},{"id":"T29","span":{"begin":65,"end":80},"obj":"Disease"},{"id":"T30","span":{"begin":104,"end":110},"obj":"Disease"},{"id":"T31","span":{"begin":169,"end":178},"obj":"Disease"},{"id":"T32","span":{"begin":193,"end":199},"obj":"Disease"}],"attributes":[{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0002771"},{"id":"A28","pred":"mondo_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/MONDO_0021187"},{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0005311"},{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"not limited to pulmonary fibrosis, hyperlipidemia, and worsening atherosclerosis. Those undergoing anti-cancer therapy are at theoretically increased susceptibility for infection, with type of cancer no"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T17","span":{"begin":15,"end":33},"obj":"Phenotype"},{"id":"T18","span":{"begin":35,"end":49},"obj":"Phenotype"},{"id":"T19","span":{"begin":65,"end":80},"obj":"Phenotype"},{"id":"T20","span":{"begin":104,"end":110},"obj":"Phenotype"},{"id":"T21","span":{"begin":150,"end":178},"obj":"Phenotype"},{"id":"T22","span":{"begin":193,"end":199},"obj":"Phenotype"}],"attributes":[{"id":"A17","pred":"hp_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/HP_0002206"},{"id":"A18","pred":"hp_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/HP_0003077"},{"id":"A19","pred":"hp_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/HP_0002621"},{"id":"A20","pred":"hp_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A21","pred":"hp_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/HP_0002719"},{"id":"A22","pred":"hp_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"not limited to pulmonary fibrosis, hyperlipidemia, and worsening atherosclerosis. Those undergoing anti-cancer therapy are at theoretically increased susceptibility for infection, with type of cancer no"}